StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2023 - 12 - 12
7
2023 - 09 - 07
10
2023 - 09 - 06
8
2023 - 05 - 01
7
2023 - 04 - 18
9
2023 - 04 - 04
8
2023 - 03 - 30
8
2023 - 03 - 07
7
2023 - 02 - 14
7
2023 - 02 - 09
10
2022 - 12 - 20
7
2022 - 12 - 12
9
2022 - 12 - 08
7
2022 - 10 - 11
10
2022 - 09 - 22
9
2022 - 08 - 11
12
2022 - 08 - 08
7
2022 - 08 - 04
8
2022 - 08 - 02
10
2022 - 08 - 01
6
2022 - 06 - 21
6
2022 - 06 - 13
6
2022 - 06 - 07
6
2022 - 05 - 18
6
2022 - 05 - 09
7
2022 - 05 - 05
6
2022 - 05 - 04
15
2022 - 04 - 25
7
2022 - 04 - 20
6
2022 - 04 - 19
8
2022 - 04 - 07
7
2022 - 03 - 30
6
2022 - 03 - 22
8
2022 - 03 - 03
6
2022 - 02 - 15
6
2022 - 02 - 01
10
2022 - 01 - 06
8
2022 - 01 - 05
9
2022 - 01 - 04
7
2021 - 12 - 20
7
2021 - 12 - 13
6
2021 - 12 - 01
6
2021 - 11 - 29
7
2021 - 11 - 22
9
2021 - 11 - 11
10
2021 - 11 - 10
10
2021 - 10 - 26
6
2021 - 09 - 13
6
2021 - 08 - 19
8
2021 - 06 - 01
6
2021 - 05 - 19
6
2021 - 05 - 05
15
2021 - 04 - 26
8
2021 - 04 - 19
6
2021 - 04 - 14
7
2021 - 04 - 13
6
2021 - 03 - 15
14
2021 - 02 - 18
6
2021 - 02 - 04
6
2021 - 01 - 05
7
Sector
Health technology
11
Miscellaneous
1
N/a
1
Retail trade
1
Tags
Acquisition
5
Air
3
Alliances
3
America
7
Antibody
4
Approval
3
Automotive
4
Awards
3
Biomidwest
3
Biopharma
3
Bioscience
3
Breast cancer
3
Cancer
6
Clinical-trials-phase-ii
4
Collaboration
4
Conference
23
Corporation
13
Day
4
Device
3
Earnings
12
Energy
14
Europe
5
Events
9
Expected
5
Fda
4
Genetown
4
Grant
6
Group
11
Growth
23
Health
4
International
5
Market
51
N/a
347
Nasdaq
3
Offering
6
One
4
Partnership
3
People
3
Pharm-country
15
Phase 1
3
Platform
5
Positive
4
Presentation
5
Program
6
Publication
3
Report
28
Repurchase
3
Research
16
Results
98
Sales
3
Security
3
Service
3
Services
4
Smart
4
Solutions
5
System
3
Technology
8
Therapeutics
19
Therapy
5
Trial
5
Entities
Adaptimmune therapeutics plc
1
Amarin corporation plc
1
Amicus therapeutics, inc.
1
Amneal pharmaceuticals, inc.
1
Annovis bio, inc.
1
Genenta science s.p.a.
1
In8bio inc
1
Iveric bio, inc.
2
Merck & company, inc.
1
Nanovibronix, inc.
1
Sanofi
1
Scynexis, inc.
1
Swk holdings corporation
1
Walgreens boots alliance, inc.
1
Symbols
ADAP
1
AMRN
1
AMRX
1
ANVS
1
FOLD
1
GNTA
1
INAB
1
ISEE
2
MRK
1
NAOV
1
SCYX
1
SNY
1
SNYNF
1
SWKH
1
WBA
1
Exchanges
Amex
1
Nasdaq
12
Nyse
2
Crawled Date
2022 - 05 - 04
15
Crawled Time
11:00
5
12:00
3
13:00
4
15:00
2
16:00
1
Source
www.biospace.com
15
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2022 - 05 - 04
tags :
Pharm-country
save search
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
Published:
2022-05-04
(Crawled : 16:00)
- biospace.com/
ADAP
|
$1.085
-4.83%
-5.07%
780K
|
Health Technology
|
-37.36%
|
O:
1.65%
H:
3.78%
C:
3.24%
Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update
Published:
2022-05-04
(Crawled : 15:00)
- biospace.com/
ANVS
|
$12.74
7.24%
-2.04%
490K
|
Health Technology
|
16.02%
|
O:
2.34%
H:
12.21%
C:
11.45%
results
Regeneron Overcomes Loss of COVID Antibody to Post Positive First Quarter
Published:
2022-05-04
(Crawled : 15:00)
- biospace.com/
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-11.9%
|
O:
-3.68%
H:
0.0%
C:
0.0%
covid
antibody
positive
IN8bio to Present at May Investor and Scientific Conferences
Published:
2022-05-04
(Crawled : 13:00)
- biospace.com/
INAB
|
$1.03
-0.96%
-0.97%
150K
|
|
-58.4%
|
O:
10.0%
H:
0.0%
C:
-1.09%
Enteris BioPharma to Exhibit at CPhI North America 2022
Published:
2022-05-04
(Crawled : 13:00)
- biospace.com/
SWKH
|
$17.1
-0.98%
-0.99%
3.3K
|
Miscellaneous
|
-11.39%
|
O:
-0.92%
H:
0.93%
C:
0.21%
america
biopharma
SCYNEXIS to Present New Data of Ibrexafungerp for Refractory Vulvovaginal Candidiasis from Ongoing Phase 3 FURI Study at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting
Published:
2022-05-04
(Crawled : 13:00)
- biospace.com/
SCYX
|
$1.495
-3.55%
-3.68%
88K
|
Health Technology
|
-41.73%
|
O:
2.26%
H:
0.0%
C:
-4.04%
ongoing
phase 3
NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS
Published:
2022-05-04
(Crawled : 13:00)
- biospace.com/
NAOV
4
|
$0.77
-5.68%
8.6K
|
Health Technology
|
13.44%
|
O:
1.92%
H:
2.62%
C:
1.14%
painshield
fda
submission
Amicus Therapeutics to Present at the Bank of America 2022 Healthcare Conference
Published:
2022-05-04
(Crawled : 12:00)
- biospace.com/
FOLD
4
|
$10.52
-1.77%
-1.81%
1.6M
|
Health Technology
|
53.11%
|
O:
0.07%
H:
3.14%
C:
2.43%
america
conference
therapeutics
Amarin Reports First Quarter 2022 Financial Results and Provides Business Update
Published:
2022-05-04
(Crawled : 12:00)
- biospace.com/
AMRN
|
News
|
$0.8844
0.13%
0.12%
660K
|
Health Technology
|
-67.95%
|
O:
-32.23%
H:
3.24%
C:
-15.68%
results
Genenta Progresses to Higher Dosing Cohort in Temferon™ Phase 1/2a Clinical Trial in Glioblastoma Multiforme
Published:
2022-05-04
(Crawled : 12:00)
- biospace.com/
GNTA
|
$3.67
1.1%
1.09%
63K
|
n/a
|
-33.88%
|
O:
4.19%
H:
1.73%
C:
-2.1%
trial
phase 1
glioblastoma
Amneal Reports First Quarter 2022 Financial Results
Published:
2022-05-04
(Crawled : 11:00)
- biospace.com/
AMRX
|
$6.07
12.41%
11.04%
3.1M
|
Health Technology
|
36.02%
|
O:
-3.02%
H:
1.17%
C:
-3.12%
results
Merck to Participate in Bank of America Securities 2022 Healthcare Conference
Published:
2022-05-04
(Crawled : 11:00)
- biospace.com/
MRK
|
$127.0
0.1%
-1.21%
7.1M
|
Health Technology
|
46.51%
|
O:
0.12%
H:
0.0%
C:
0.0%
america
conference
AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
Published:
2022-05-04
(Crawled : 11:00)
- biospace.com/
WBA
4
|
$17.82
-1.27%
-1.29%
10M
|
Retail Trade
|
-57.75%
|
O:
0.54%
H:
3.77%
C:
3.52%
results
Iveric Bio Announces Presentation of Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
Published:
2022-05-04
(Crawled : 11:00)
- biospace.com/
ISEE
|
$39.95
0.38%
0.38%
0
|
Health Technology
|
176.77%
|
O:
-0.28%
H:
4.39%
C:
4.25%
zimura
trial
presentation
Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results
Published:
2022-05-04
(Crawled : 11:00)
- biospace.com/
ISEE
|
$39.95
0.38%
0.38%
0
|
Health Technology
|
176.77%
|
O:
-0.28%
H:
4.39%
C:
4.25%
results
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.